318 results on '"Etrych T"'
Search Results
2. Adaptable polymerization platform for therapeutics with tunable biodegradability
3. Size-switchable polymer-based nanomedicines in the advanced therapy of rheumatoid arthritis
4. Chemosensitization of tumors via simultaneous delivery of STAT3 inhibitor and doxorubicin through HPMA copolymer-based nanotherapeutics with pH-sensitive activation
5. Polymer nitric oxide donors potentiate the treatment of experimental solid tumours by increasing drug accumulation in the tumour tissue
6. Biocompatible glyconanomaterials based on HPMA-copolymer for specific targeting of galectin-3
7. New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting
8. Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: In vitro effect of extra drug-free GlyPheLeuGly sequences
9. Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNA
10. Immunotherapy of cancer with polymeric prodrugs: from dream to reality: WS 1-6
11. Cytotoxic and Immunomodulatory Activites of Polymer-Bound Drugs
12. HPMA copolymer conjugates for dual therapy
13. Biodegradable high-molecular-weight polymer drug carriers based on HPMA copolymers
14. Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: In vitro effect of extra drug-free GlyPheLeuGly sequences
15. The mechanism of cytotoxicity of HPMA-based polymeric prodrugs depends on their intracellular pathway: 171
16. Unmasking tumour for the immune system: HPMA-based copolymers with pH-controlled release of doxorubicin in anti-cancer therapy: 167
17. Polymer-drug conjugates with pH-controlled drug release: 165
18. Polymeric anticancer drugs with pH-controlled activation
19. HPMA copolymers containing doxorubicin bound by a proteolytically or hydrolytically cleavable bond: comparison of biological properties in vitro
20. HPMA copolymer-bound doxorubicin targeted to tumor-specific antigen of BCL1 mouse B cell leukemia
21. Polymeric anticancer drugs with pH-controlled activation
22. HPMA copolymers with pH-controlled release of doxorubicin: In vitro cytotoxicity and in vivo antitumor activity
23. Oligopeptide-targeted polymer nanoprobes for fluorescence-guided endoscopic surgery
24. Differences in the intracellular fate of free and polymer-bound doxorubicin
25. HPMA-hydrogels result in prolonged delivery of anticancer drugs and are a promising tool for the treatment of sensitive and multidrug resistant leukaemia
26. Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes
27. Polymeric Nanogels as Drug Delivery Systems
28. Synthesis of Water-Soluble Star Polymers Based on Cyclodextrins
29. Cell-Penetrating Peptides: a Useful Tool for the Delivery of Various Cargoes Into Cells
30. Polymer-Drug Conjugates in Inflammation Treatment
31. Drug Carriers With Star Polymer Structures
32. Overcoming multidrug resistance using folate receptor-targeted and pH-responsive polymeric nanogels containing covalently entrapped doxorubicin
33. Glycan-decorated HPMA copolymers as high-affinity lectin ligands
34. Star Polymer-Drug Conjugates with pH-Controlled Drug Release and Carrier Degradation
35. Intracellular Fate of Polymer Therapeutics Investigated by Fluorescence Lifetime Imaging and Fluorescence Pattern Analysis
36. The pH-Dependent and Enzymatic Release of Cytarabine From Hydrophilic Polymer Conjugates
37. HPMA Copolymer-Based Polymer Conjugates for the Delivery and Controlled Release of Retinoids
38. High-Molecular-Weight HPMA-Based Polymer Drug Carriers for Delivery to Tumor
39. Micelle-forming HPMA copolymer conjugates of ritonavir bound via a pH-sensitive spacer with improved cellular uptake designed for enhanced tumor accumulation
40. PCL–PEG graft copolymers with tunable amphiphilicity as efficient drug delivery systems
41. In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
42. The Comparison of In Vivo Properties of Water-Soluble HPMA-Based Polymer Conjugates with Doxorubicin Prepared by Controlled RAFT or Free Radical Polymerization
43. Nanotherapeutics With Anthracyclines: Methods of Determination and Quantification of Anthracyclines in Biological Samples
44. Nanotherapeutics Shielded With a pH Responsive Polymeric Layer
45. High-molecular weight star conjugates containing docetaxel with high anti-tumor activity and low systemic toxicity in vivo
46. Polymer-coated polyplexes designed for triggered activation utilising intracellular reduction
47. HPMA Copolymer-Bound Doxorubicin Induces Immunogenic Tumor Cell Death
48. Synthesis of Well-Defined Semitelechelic Poly[N-(2-hydroxypropyl)methacrylamide] Polymers with Functional Group at the α-End of the Polymer Chain by RAFT Polymerization
49. Novel star HPMA-based polymer conjugates for passive targeting to solid tumors
50. Micellar and Antibody‐Targeted Polymer Therapeutics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.